Eli Lilly CEO: The Weight-Loss Drug Revolutio...

We've curated a special 10-minute version of the podcast for those in a hurry. Here you can listen to the full episode: https://podcasts.apple.com/no/podcast/mike-gitlin-inside-capital-groups-philosophy-ownership/id1614211565?i=1000749180724&l=nbIn this episode, Nicolai Tangen si ...  Show more

In this episode, Nicolai Tangen sits down with Mike Gitlin, President and CEO of Capital Group, one of the world’s largest investment managers. They discuss Capital Group’s distinctive investment model, its long-term philosophy, and the firm’s unique ownership structure that has ...  Show more

In this episode of the What the FinTech? podcast, host and FinTech Futures editor Paul Hindle is joined by Paul Noble, CEO of Chetwood Bank, to explore how the Wrexham-based bank has set about its product and tech innovation strategy as it looks to continue its growth trajectory, ...  Show more

In this episode, Ray and Peter discuss the changing world order, China vs. the USA, and Ray’s thoughts on the future of the US. Recorded on Feb 3rd, 2025 Views are my own thoughts; not Financial, Medical, or Legal Advice. Ray Dalio is a renowned investor, hedge fund manager, an ...  Show more

(0:00) Introducing Eli Lilly CEO Dave Ricks

(1:43) How Eli Lilly discovered the GLP-1 impact on weight loss, counterfeit products from China

(7:08) GLP-1 pricing and capital allocation after a breakout pharma product

(12:56) Why Biotech VC has plummeted, " ...

My guest today is Jeff Horing. Jeff cofounded Insight Partners and has been the Managing Director since 1995. This is one of Jeff’s first public conversations about building one of the world’s most successful technology investment firms with over $100 billion in AUM. Jeff reveals ...  Show more